Studies have demonstrated that Bcl2L12 co-localizes and binds to p53 in the nucleus of gliomas, inhibiting the transcriptional regulation of p53 by interfering with its binding to target genes [34]. This evidence concerns the gene BCL2L12 and central nervous system cancer.